Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Ovarian Neoplasms

  Free Subscription


Articles published in Am J Surg Pathol

Retrieve available abstracts of 33 articles:
HTML format



Single Articles


    May 2020
  1. LESKELA S, Romero I, Cristobal E, Perez-Mies B, et al
    Mismatch Repair Deficiency in Ovarian Carcinoma: Frequency, Causes, and Consequences.
    Am J Surg Pathol. 2020;44:649-656.
    PubMed     Abstract available


    January 2020
  2. ARNESEN C, Eich ML, Pena MR, Cappel JR, et al
    NKX3.1 and Prostein Expression in Testicular Tissue and Sex Cord-stromal Tumors.
    Am J Surg Pathol. 2020;44:61-67.
    PubMed     Abstract available


    December 2019
  3. ZAREI S, Wang Y, Jenkins SM, Voss JS, et al
    Clinicopathologic, Immunohistochemical, and Molecular Characteristics of Ovarian Serous Carcinoma With Mixed Morphologic Features of High-grade and Low-grade Serous Carcinoma.
    Am J Surg Pathol. 2019 Dec 23. doi: 10.1097/PAS.0000000000001419.
    PubMed     Abstract available


    November 2019
  4. KIHARA A, Amano Y, Yoshimoto T, Matsubara D, et al
    Stromal p16 Expression Helps Distinguish Atypical Polypoid Adenomyoma From Myoinvasive Endometrioid Carcinoma of the Uterus.
    Am J Surg Pathol. 2019;43:1526-1535.
    PubMed     Abstract available


  5. XING D, Zhong M, Ye F, O'Malley MT, et al
    Ovarian Intermediate Trophoblastic Tumors: Genotyping Defines a Distinct Category of Nongestational Tumors of Germ Cell Type.
    Am J Surg Pathol. 2019 Nov 1. doi: 10.1097/PAS.0000000000001402.
    PubMed     Abstract available


    October 2019
  6. LAWSON BC, Euscher ED, Bassett RL, Liu J, et al
    A 3-Tier Chemotherapy Response Score for Ovarian/Fallopian Tube/Peritoneal High-grade Serous Carcinoma: Is it Clinically Relevant?
    Am J Surg Pathol. 2019 Oct 22. doi: 10.1097/PAS.0000000000001391.
    PubMed     Abstract available


    September 2019
  7. LESKELA S, Romero I, Cristobal E, Perez-Mies B, et al
    The Frequency and Prognostic Significance of the Histologic Type in Early-stage Ovarian Carcinoma: A Reclassification Study by the Spanish Group For Ovarian Cancer Research (GEICO).
    Am J Surg Pathol. 2019 Sep 6. doi: 10.1097/PAS.0000000000001365.
    PubMed     Abstract available


    July 2019
  8. CHUI MH, Xing D, Zeppernick F, Wang ZQ, et al
    Clinicopathologic and Molecular Features of Paired Cases of Metachronous Ovarian Serous Borderline Tumor and Subsequent Serous Carcinoma.
    Am J Surg Pathol. 2019 Jul 23. doi: 10.1097/PAS.0000000000001325.
    PubMed     Abstract available


  9. PARRA-HERRAN C, Bassiouny D, Lerner-Ellis J, Olkhov-Mitsel E, et al
    p53, Mismatch Repair Protein, and POLE Abnormalities in Ovarian Clear Cell Carcinoma: An Outcome-based Clinicopathologic Analysis.
    Am J Surg Pathol. 2019 Jul 19. doi: 10.1097/PAS.0000000000001328.
    PubMed     Abstract available


    May 2019
  10. ASAKA S, Davis C, Lin SF, Wang TL, et al
    Analysis of Telomere Lengths in p53 Signatures and Incidental Serous Tubal Intraepithelial Carcinomas Without Concurrent Ovarian Cancer.
    Am J Surg Pathol. 2019 May 17. doi: 10.1097/PAS.0000000000001283.
    PubMed     Abstract available


  11. LEE CH, Kao YC, Lee WR, Hsiao YW, et al
    Clinicopathologic Characterization of GREB1-rearranged Uterine Sarcomas With Variable Sex-Cord Differentiation.
    Am J Surg Pathol. 2019 May 13. doi: 10.1097/PAS.0000000000001265.
    PubMed     Abstract available


  12. KARNEZIS AN, Wang Y, Keul J, Tessier-Cloutier B, et al
    DICER1 and FOXL2 Mutation Status Correlates With Clinicopathologic Features in Ovarian Sertoli-Leydig Cell Tumors.
    Am J Surg Pathol. 2019;43:628-638.
    PubMed     Abstract available


    April 2019
  13. NOLAN A, Buza N, Margeta M, Rabban JT, et al
    Ovarian Teratomas in Women With Anti-N-methyl-D-Aspartate Receptor Encephalitis: Topography and Composition of Immune Cell and Neuroglial Populations is Compatible With an Autoimmune Mechanism of Disease.
    Am J Surg Pathol. 2019 Apr 23. doi: 10.1097/PAS.0000000000001249.
    PubMed     Abstract available


    March 2019
  14. SARI A, Pollett A, Eiriksson LR, Lumsden-Johanson B, et al
    Interobserver Agreement for Mismatch Repair Protein Immunohistochemistry in Endometrial and Nonserous, Nonmucinous Ovarian Carcinomas.
    Am J Surg Pathol. 2019 Mar 8. doi: 10.1097/PAS.0000000000001220.
    PubMed     Abstract available


    September 2018
  15. BENNETT JA, Pesci A, Morales-Oyarvide V, Da Silva A, et al
    Incidence of Mismatch Repair Protein Deficiency and Associated Clinicopathologic Features in a Cohort of 104 Ovarian Endometrioid Carcinomas.
    Am J Surg Pathol. 2018 Sep 25. doi: 10.1097/PAS.0000000000001165.
    PubMed     Abstract available


  16. PARRA-HERRAN C, Bassiouny D, Vicus D, Olkhov-Mitsel E, et al
    FIGO Versus Silverberg Grading Systems in Ovarian Endometrioid Carcinoma: A Comparative Prognostic Analysis.
    Am J Surg Pathol. 2018 Sep 12. doi: 10.1097/PAS.0000000000001160.
    PubMed     Abstract available


    March 2018
  17. BOSSE T, Nout RA, McAlpine JN, McConechy MK, et al
    Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups.
    Am J Surg Pathol. 2018 Mar 2. doi: 10.1097/PAS.0000000000001020.
    PubMed     Abstract available


    February 2018
  18. MIRKOVIC J, McFarland M, Garcia E, Sholl LM, et al
    Targeted Genomic Profiling Reveals Recurrent KRAS Mutations in Mesonephric-like Adenocarcinomas of the Female Genital Tract.
    Am J Surg Pathol. 2018;42:227-233.
    PubMed     Abstract available


    January 2018
  19. ASSEM H, Rambau PF, Lee S, Ogilvie T, et al
    High-grade Endometrioid Carcinoma of the Ovary: A Clinicopathologic Study of 30 Cases.
    Am J Surg Pathol. 2018 Jan 5. doi: 10.1097/PAS.0000000000001016.
    PubMed     Abstract available


    October 2017

  20. Ovarian Microcystic Stromal Tumors are Characterized by Alterations in the Beta-Catenin-APC Pathway and May be an Extracolonic Manifestation of Familial Adenomatous Polyposis.
    Am J Surg Pathol. 2017 Oct 26. doi: 10.1097/PAS.0000000000000981.
    PubMed    


    September 2017
  21. YANG C, Sun L, Zhang L, Zhou L, et al
    Diagnostic Utility of SATB2 in Metastatic Krukenberg Tumors of the Ovary: An Immunohistochemical Study of 70 Cases With Comparison to CDX2, CK7, CK20, Chromogranin, and Synaptophysin.
    Am J Surg Pathol. 2017 Sep 13. doi: 10.1097/PAS.0000000000000951.
    PubMed     Abstract available


  22. SAVAGE J, Adams E, Veras E, Murphy KM, et al
    Choriocarcinoma in Women: Analysis of a Case Series With Genotyping.
    Am J Surg Pathol. 2017 Sep 4. doi: 10.1097/PAS.0000000000000937.
    PubMed     Abstract available


  23. CHAPEL DB, Husain AN, Krausz T, McGregor SM, et al
    PAX8 Expression in a Subset of Malignant Peritoneal Mesotheliomas and Benign Mesothelium has Diagnostic Implications in the Differential Diagnosis of Ovarian Serous Carcinoma.
    Am J Surg Pathol. 2017 Sep 4. doi: 10.1097/PAS.0000000000000935.
    PubMed     Abstract available


  24. DE KOCK L, Terzic T, McCluggage WG, Stewart CJR, et al
    DICER1 Mutations Are Consistently Present in Moderately and Poorly Differentiated Sertoli-Leydig Cell Tumors.
    Am J Surg Pathol. 2017;41:1178-1187.
    PubMed     Abstract available


  25. GRU AA, Williams ES, Cao D
    Mixed Gonadal Germ Cell Tumor Composed of a Spermatocytic Tumor-Like Component and Germinoma Arising in Gonadoblastoma in a Phenotypic Woman With a 46, XX Peripheral Karyotype: Report of the First Case.
    Am J Surg Pathol. 2017;41:1290-1297.
    PubMed     Abstract available


    June 2017
  26. VANG R, Hannibal CG, Junge J, Frederiksen K, et al
    Long-term Behavior of Serous Borderline Tumors Subdivided Into Atypical Proliferative Tumors and Noninvasive Low-grade Carcinomas: A Population-based Clinicopathologic Study of 942 Cases.
    Am J Surg Pathol. 2017;41:725-737.
    PubMed     Abstract available


    May 2017
  27. MESBAH ARDAKANI N, Giardina T, Amanuel B, Stewart CJ, et al
    Molecular Profiling Reveals a Clonal Relationship Between Ovarian Mucinous Tumors and Corresponding Mural Carcinomatous Nodules.
    Am J Surg Pathol. 2017 May 11. doi: 10.1097/PAS.0000000000000875.
    PubMed     Abstract available


    April 2017
  28. KIHARA A, Yoshida H, Watanabe R, Takahashi K, et al
    Clinicopathologic Association and Prognostic Value of Microcystic, Elongated, and Fragmented (MELF) Pattern in Endometrial Endometrioid Carcinoma.
    Am J Surg Pathol. 2017 Apr 17. doi: 10.1097/PAS.0000000000000856.
    PubMed     Abstract available


    January 2017
  29. RAMBAU PF, McIntyre JB, Taylor J, Lee S, et al
    Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the Ovary.
    Am J Surg Pathol. 2017 Jan 25. doi: 10.1097/PAS.0000000000000812.
    PubMed     Abstract available


    October 2016
  30. JOEHLIN-PRICE AS, McHugh KE, Stephens JA, Li Z, et al
    The Microcystic, Elongated, and Fragmented (MELF) Pattern of Invasion: A Single Institution Report of 464 Consecutive FIGO Grade 1 Endometrial Endometrioid Adenocarcinomas.
    Am J Surg Pathol. 2016.
    PubMed     Abstract available


    August 2016
  31. AHN G, Folkins AK, McKenney JK, Longacre TA, et al
    Low-grade Serous Carcinoma of the Ovary: Clinicopathologic Analysis of 52 Invasive Cases and Identification of a Possible Noninvasive Intermediate Lesion.
    Am J Surg Pathol. 2016.
    PubMed     Abstract available


    July 2016
  32. MCKENNEY JK, Gilks CB, Kalloger S, Longacre TA, et al
    Classification of Extraovarian Implants in Patients With Ovarian Serous Borderline Tumors (Tumors of Low Malignant Potential) Based on Clinical Outcome.
    Am J Surg Pathol. 2016.
    PubMed     Abstract available


    June 2016
  33. BARTOSCH C, Pires-Luis AS, Meireles C, Baptista M, et al
    Pathologic Findings in Prophylactic and Nonprophylactic Hysterectomy Specimens of Patients With Lynch Syndrome.
    Am J Surg Pathol. 2016.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: